Related Articles
Dihydroartemisinin inhibits endothelial cell proliferation through the suppression of the ERK signaling pathway
Dihydroartemisinin induces endothelial cell anoikis through the activation of the JNK signaling pathway Corrigendum in /10.3892/ol.2017.6464
Dihydroartemisinin inhibits vascular endothelial growth factor‑induced endothelial cell migration by a p38 mitogen‑activated protein kinase‑independent pathway
Dihydroartemisinin attenuates lipopolysaccharide‑induced acute lung injury in mice by suppressing NF‑κB signaling in an Nrf2‑dependent manner
Dihydroartemisinin sensitizes Lewis lung carcinoma cells to carboplatin therapy via p38 mitogen-activated protein kinase activation